Multidrug-Resistant Acinetobacter baumannii Osteomyelitis from Iraq

Multidrug-Resistant Acinetobacter baumannii Osteomyelitis from Iraq

Bibliographic Details
Main Authors:	Jason J. Schafer, Julie E. Mangino
Format:	Article
Language:	English
Published:	Centers for Disease Control and Prevention 2008-03-01
Series:	Emerging Infectious Diseases
Subjects:	Acinetobacter baumannii tigecycline osteomyelitis multidrug resistance letter Iraq
Online Access:	https://wwwnc.cdc.gov/eid/article/14/3/07-0128_article

Similar Items

Multidrug-Resistant Acinetobacter baumannii
by: Vladimir Krcmery, et al.
Published: (2007-06-01)

Colistin and tigecycline for management of external ventricular device-related ventriculitis due to multidrug-resistant Acinetobacter baumannii
by: Gentle Sunder Shrestha, et al.
Published: (2016-07-01)

Comparison of minimal inhibitory concentrations (MICs) of tigecycline in 2011 and 2015 years against multidrug-resistance acinetobacter baumannii strains
by: Yucel Duman, et al.
Published: (2017-03-01)

Multidrug Resistant Brain Abscess Due to Acinetobacter baumannii Ventriculitis Cleared by Intraventricular and Intravenous Tigecycline Therapy: A Case Report and Review of Literature
by: Wenyong Long, et al.
Published: (2018-06-01)

Isolation of bacteriophages against multidrug resistant Acinetobacter baumannii
by: Hasan Ghajavand, et al.
Published: (2017-01-01)

Clinical experience with tigecycline in the treatment of hospital-acquired pneumonia caused by multidrug resistant Acinetobacter baumannii
by: Yangang Zhou, et al.
Published: (2019-04-01)

Optimal Therapy for Multidrug-Resistant Acinetobacter baumannii
by: Burke A. Cunha, et al.
Published: (2010-01-01)

Factors influencing survival in patients with multidrug-resistant Acinetobacter baumannii infection
by: Mariana Lima Prata-Rocha, et al.

Comparison of Tigecycline or Cefoperazone/Sulbactam therapy for bloodstream infection due to Carbapenem-resistant Acinetobacter baumannii
by: Tianshui Niu, et al.
Published: (2019-03-01)

Multidrug-Resistant Acinetobacter baumannii
by: Aharon Abbo, et al.
Published: (2005-01-01)

Prolonged and high dosage of tigecycline – successful treatment of spondylodiscitis caused by multidrug-resistant Acinetobacter baumannii: a case report
by: Olga Tsachouridou, et al.
Published: (2017-07-01)

Tigecycline treatment in an infant with extensively drug-resistant Acinetobacter baumannii bacteremia
by: Jiawei Zeng, et al.
Published: (2017-08-01)

Influencing factors of successful eradication of multidrug-resistant Acinetobacter baumannii in the respiratory tract with aerosolized colistin
by: Yu-Mu Chen, et al.
Published: (2014-10-01)

Successful Treatment With Intrathecal and Intravenous Polymyxin B-Based Combination Against MDR Acinetobacter baumannii Meningitis in Pediatric Patient: A Case Report
by: Haiyan Xing, et al.
Published: (2021-07-01)

Antibiotics Combinations and Chitosan Nanoparticles for Combating Multidrug Resistance Acinetobacter baumannii
by: Banoub NG, et al.
Published: (2021-08-01)

In vitro activity of tigecycline against clinical isolates of carbapenem resistant <it>Acinetobacter baumannii</it> complex in Pretoria, South Africa
by: Ahmed Nahid H, et al.
Published: (2012-05-01)

A bronchofiberoscopy-associated outbreak of multidrug-resistant <it>Acinetobacter baumannii</it> in an intensive care unit in Beijing, China
by: Xia Yukun, et al.
Published: (2012-12-01)

Biofilm formation in clinical isolates of nosocomial Acinetobacter baumannii and its relationship with multidrug resistance
by: Ebrahim Babapour, et al.
Published: (2016-06-01)

Relative Gene Expression of RND-Type Efflux Pumps in Tigecycline Resistant Acinetobacter Baumannii Isolated from Training Hospitals in Tehran, Iran
by: Mina Owrang, et al.
Published: (2018-12-01)

Role of Efflux Pump Gene adeIJK to Multidrug Resistance in Acinetobacter baumanniiClinical Isolates
by: Ji Ae Choi, et al.
Published: (2020-03-01)

Bloodstream infections caused by ST2 Acinetobacter baumannii: risk factors, antibiotic regimens, and virulence over 6 years period in China
by: Kaihang Yu, et al.
Published: (2021-01-01)

High-Dose Tigecycline in Elderly Patients with Pneumonia Due to Multidrug-Resistant Acinetobacter baumannii in Intensive Care Unit
by: Bai XR, et al.
Published: (2020-05-01)

Molecular Characterization of Multiple Antibiotic-Resistant Acinetobacter baumannii Isolated from Egyptian Patients
by: Aya A. Khodier, et al.
Published: (2020-12-01)

Efficacy of Mastoparan-AF alone and in combination with clinically used antibiotics on nosocomial multidrug-resistant Acinetobacter baumannii
by: Chun-Hsien Lin, et al.
Published: (2017-07-01)

Investigation of the Characteristics of Multidrug-Resistant (MDR) Acinetobacter Baumannii Lytic Phage Isolated from the Intensive Care Unit
by: Behnam Sisakhtpour, et al.
Published: (2019-08-01)

The Transcriptomic Signature of Tigecycline in Acinetobacter baumannii
by: Liping Li, et al.
Published: (2020-10-01)

The emergence of Acinetobacter baumannii ST-6 multidrug resistant: A resilient biofilm producer, Malaysia
by: Desa, M.N.M, et al.
Published: (2016)

Determination of Colistin and Tigecycline Resistance Profile of Acinetobacter Baumannii Strains from Different Clinical Samples in a Territory Hospital in Turkey
by: Merih Şimşek, et al.
Published: (2020-03-01)

iTRAQ-Based Differential Proteomic Analysis Reveals the Pathways Associated with Tigecycline Resistance in Acinetobacter baumannii
by: Ni Yang, et al.
Published: (2018-11-01)

Multidrug-Resistant Acinetobacter baumannii Harboring OXA-24 Carbapenemase, Spain
by: Joshi Acosta, et al.
Published: (2011-06-01)

Prevalence and Characterization of Integrons in Multidrug Resistant Acinetobacter baumannii in Eastern China: A Multiple-Hospital Study
by: Jing Chen, et al.
Published: (2015-08-01)

In Vitro Activities of Various Antimicrobials Against Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii Strains Isolated from Intensive Care Units
by: Arzu ŞENOL, et al.
Published: (2021-03-01)

Molecular epidemiology of multidrug-resistant Acinetobacter baumannii isolates from hospitals in Myanmar
by: Tatsuya Tada, et al.
Published: (2020-09-01)

Clinical Outcomes and Safety of Meropenem–Colistin versus Meropenem–Tigecycline in Patients with Carbapenem-Resistant <i>Acinetobacter baumannii</i> Pneumonia
by: Jae-Min Park, et al.
Published: (2021-07-01)

Genetic Background of Carbapenem Resistant Acinetobacter baumannii in a Health Care Setting in Alexandria, Egypt
by: Amira Amine, et al.
Published: (2011-09-01)

Burden of Multidrug-Resistant Acinetobacter baumannii Infection in Hospitalized Patients in a Tertiary Care Hospital of Nepal
by: Yadav SK, et al.
Published: (2020-03-01)

Antibacterial activity of Hibiscus sabdariffa L. calyces against hospital isolates of multidrug resistant Acinetobacter baumannii
by: Emad Mohamed Abdallah
Published: (2016-11-01)

Retrospective comparative analysis of risk factors and outcomes in patients with carbapenem resistant Acinetobacter baumannii bloodstream infections: cefoperazone–sulbactam associated with resistance and tigecycline increased the mortality
by: Niu T, et al.
Published: (2018-10-01)

Detection of colistin sensitivity in clinical isolates of Acinetobacter baumannii in Iran
by: Bahareh Vakili, et al.
Published: (2014-01-01)

Decreasing Prevalence of Multidrug-Resistant Acinetobacter Baumannii in Rīga East University Hospital / Multirezistentās Acinetobacter Baumannii Izplatības Mazināšanās Rīgas Austrumu Klīniskajā Universitātes Slimnīcā
by: Liepiņš Māris, et al.
Published: (2016-08-01)